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A B S T R A C T
The plakin family of cytolinkers interacts with intermediate filaments (IFs) through plakin repeat domain (PRD)
and linker modules. Recent structure/function studies have established the molecular basis of envoplakin-PRD
and periplakin-linker interactions with vimentin. Both plakin modules share a broad basic groove which re-
cognizes acidic rod elements on IFs, a mechanism that is applicable to other plakin family members. This review
postulates a universal IF engagement mechanism that illuminates the specific effects of pathogenic mutations
associated with diseases including arrhythmogenic right ventricular cardiomyopathy, and reveals how diverse
plakin proteins offer tailored IF tethering to ensure stable, dynamic and regulated cellular structures.
1. Introduction
Plakin proteins form cell-cell and cell-matrix junctions and link to
organelles such as mitochondria and nuclei by engaging intermediate
filaments (IFs), actin microfilaments and microtubules. The seven
mammalian members include desmoplakin, envoplakin, periplakin,
plectin, bullous pemphigoid antigen 1 (BPAG1), microtubule-actin
cross-linking factor 1 (MACF1) and epiplakin. In addition to PRD and
linker modules, their architectures comprise plakin, actin-binding,
coiled-coil rod, growth-arrest-specific 2-related (GAR) and glycine-
serine-arginine-rich (GSR) domains (Fig. 1A), as well as spectrin repeat
regions and EF hands. As such, they act as cytoskeletal adapters that
facilitate cell adhesion, migration, signalling and the stress response
[1–3]. Plakin proteins are widely distributed in tissues including epi-
thelia, cardiac muscle and skeletal muscle and mediate specialized
functions. Desmoplakin is essential for cell-cell adhesion in desmo-
somes, envoplakin and periplakin serve as scaffolds in the cornified
envelope, plectin and BPAG1 contribute to cell-matrix adhesion in
hemidesmosomes, MACF1 figures in microtubule stabilisation and cell
motility and epiplakin supports stress responses [1–3]. Due to their
essential role in maintaining tissue integrity and resilience, compro-
mised plakin function can lead to genetic and autoimmune diseases,
with the structural mechanisms involved now becoming clearer.
Alternative splicing of plakin proteins endows family members with
a myriad of tissue-specific functions. These include not just binding to
IFs but also to actin microfilaments via N-terminal actin-binding do-
mains, to microtubules by means of C-terminal GSR and GAR motifs,
and to transmembrane assemblies through their N-terminal plakin do-
mains [1–3]. Here we focus on recent insights into the mechanisms
governing IF interactions, which are mediated by PRD and linker
modules, and explain how these interactions are affected by pathogenic
disease-causing mutations.
2. Interaction of plakin proteins with IFs
Plakin proteins interact with the cell-type specific IF proteins
desmin, keratin and vimentin. These proteins feature a long α-helical
rod domain consisting of four heptad repeat containing regions (coils
1A, 1B, 2A and 2B) interspersed by three short intervening segments
(L1, L12 and L2) (Fig. 1B). The conserved extremities of the rod domain
have critical roles in IF assembly, with even subtle amino acid sub-
stitutions leading to dramatic consequences [4]. The central rod do-
main is flanked by unstructured, poorly conserved N- and C-terminal
regions, completing the characteristic tripartite domain structure
shared by IF proteins. Their hierarchical assembly involves two elon-
gated protein subunits forming parallel coiled-coil hetero- (keratin) or
homo- (desmin and vimentin) dimers which subsequently form anti-
parallel tetramers. Tetramers then associate laterally and longitudinally
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to assemble mature 10 nm-wide elongated compacted filaments of
varying lengths [5,6].
Plakin proteins possess varying numbers of PRDs from one in en-
voplakin to thirteen in epiplakin. Periplakin lacks a PRD but does have
a linker module, in common with several other plakin proteins
(Fig. 1A). Most plakin proteins bind IFs through a cluster of PRD and
linker modules at their C-termini. This allows desmoplakin to recognize
coil 1 of keratins 5 and 14, keratins 1 and 10, desmin and vimentin [7],
and plectin to engage the equivalent region of keratins 5 and 14 [8].
The sole PRD of envoplakin binds to coil 1A of vimentin [9]. Together,
this indicates that plakin C-termini generally engage overlapping se-
quences conserved within the coil 1 region of IF proteins. By contrast,
the PRDs of BPAG1b and MACF1b are more centrally located between
the plakin domain and the spectrin repeat region and it remains unclear
whether they mediate IF interactions [10,11]. Epiplakin is comprised
exclusively of PRDs and binds only to IF proteins, particularly keratin
[12].
Linker modules are typically found immediately preceding the
“PRD-C”-type domain, which is found at the C-terminus of desmo-
plakin, envoplakin, plectin, and BPAG1e (Fig. 1A). Periplakin is unique
in that its linker module is its only means of mediating direct IF
binding. The ability of linker domains to bind IFs varies. The periplakin
linker associates with IFs in overlay assays, yeast two-hybrid and pull-
down assays whereas no such interaction is evident with the envoplakin
linker [13,14]. A periplakin construct comprising part of its rod domain
and its linker co-localises with IFs in cells whereas an analogous en-
voplakin construct (including the C-terminal PRD) shows limited, par-
tial co-localisation [13]. When co-transfected, both constructs co-loca-
lise with IFs [9,13]. Hence periplakin appears to recruit envoplakin to
the IF cytoskeleton, presumably through heterodimerisation of their rod
elements.
There are pathological consequences when interactions between
plakins and IFs are compromised. Lethal acantholytic epidermolysis
bullosa is a skin blistering disease that is caused by recessive hetero-
zygous truncations in the desmoplakin gene that eliminate C-terminal
IF binding sub-domains. Keratinocyte cell-cell adhesion is compromised
and the subsequent skin blistering causes catastrophic fluid loss and
early death [15]. Carvajal syndrome is caused by a recessive homo-
zygous truncation that removes part of the desmoplakin linker module
and all of PRD3-C, and clinically manifests as cardiomyopathy, pal-
moplantar keratoderma and woolly hair [16]. Numerous mutations
within desmoplakin's PRD and linker modules result in arrhythmogenic
right ventricular cardiomyopathy (ARVC), a common cause of sudden
cardiac arrest and death in young adults [17,18], with reduced IF
binding being one potential cause of the pathology [19]. Related con-
ditions include epidermolysis bullosa simplex (EBS), a skin blistering
disease that is linked to mutations in genes encoding plectin and BPAG1
(although the majority of the mutations that cause EBS occur in keratin
5 and keratin 14). In EBS mutations often lead to IF aggregation but in a
subset of cases skin blistering has been attributed to defective IF an-
chorage at the hemidesmosome [20].
The various IF protein mutations and associated diseases reported in
the Intermediate Filament Database (www.interfil.org) include>60
keratin alterations,> 10 desmin mutations and one vimentin sub-
stitution [21]. A further mutation in vimentin has recently been
described [22]. The majority of these mutations are thought to be pa-
thogenic due to predicted effects on IF structure and assembly. Keratin
mutations primarily affect the skin and hair, and can cause tissue fra-
gility, blistering, hyperkeratosis, hyperproliferation and IF aggregation
[23]. Desmin mutations principally affect muscle and the heart and
often lead to filament aggregation, progressive muscle damage and
cardiomyocyte degeneration [24]. Interestingly desmin mutation
E108K, that results in dilated cardiomyopathy, fails to disrupt desmin
network architecture in human smooth muscle cells and neonatal rat
cardiac myocytes [25]. This residue is conserved in coil 1A of type I-III
IF proteins, the region that mediates desmoplakin binding [7], so it is
conceivable that defective desmoplakin-desmin binding could explain
its pathogenic effect.
3. Structures of plakin repeat domain and linker modules
In addition to the three established classes of PRDs (A/B/C), a
fourth subtype (D) is present in plectin, BPAG1e and epiplakin [9]
(Fig. 1C). All PRDs contain 4.5 copies of the canonical 38-residue plakin
repeat (PR) motif [26], which includes an 11 residue β-hairpin followed
by an antiparallel pair of α-helices. The crystal structures of the des-
moplakin PRD1-A, PRD2-B, PRD3-C and envoplakin PRD-C modules
(Fig. 2A), and the solution structure of plectin PRD6-C (PDB: 2N03),
display a large positively charged groove lined with several conserved
amino acids that could accommodate IF rods [9,27,28]. PRDs A/B/D
also include an additional N-terminal (Nt) PR-like motif characterised
by a β-hairpin followed by three antiparallel α-helices. The periplakin
linker structure (PDB: 4Q28) features a distinct PR-like motif at each
end of the protein. The smaller Nt-PR-like pattern aligns well with the
PR2 motif, whereas the larger C-terminal PR-like module resembles the
Nt-PR-like elements found in desmoplakin PRDs-A and B. The two PR
motifs within the periplakin linker form an elongated bi-lobed domain
that frames an electropositive groove (Fig. 2B) that, like that of PRDs,
could accommodate an IF rod bearing a multi-acidic surface [28,29].
4. Molecular basis of plakin protein-IF interactions
The mechanism responsible for plakin recognition of IFs involves
coiled-coil rods slotting into the basic grooves of PRDs and linkers. This
electrostatic complementarity can be disrupted with either charge re-
versal mutation of basic residues (K1901 and R1914) in the positively
charged groove of envoplakin's PRD or of acidic residues (D112 and
D119) in the vimentin coil 1A, compromising direct interactions [9].
Accordingly, mutation of the K1901 and R1914 binding determinants
delocalise envoplakin constructs in cells [9]. The interface is stabilised
by ionic interactions mediated between basic residues emanating from
the PRD groove and acidic side-chains projecting from the vimentin coil
1A domain (Fig. 2C). Non-polar residues and other factors such as steric
fit may also contribute to the interface as charge reversal substitutions
fail to completely abolish PRD-vimentin ligand interactions [9]. Dif-
ferent vimentin fragments can be accommodated by the envoplakin
PRD, albeit with various angles of vimentin slotting into the groove.
This infers that PRD modules are presented with different opportunities
for sliding and locking onto filaments, facilitating the dynamic as-
sembly and disassembly of junctional complexes between epithelial cell
Fig. 1. A) Domain architecture of plakin proteins. Mammalian plakins that possess plakin repeat domains (PRDs) and/or linker modules are displayed, with
alternatively spliced versions that lack PRDs omitted. The plakin domain consists of a variable number of spectrin repeats and a Src homology 3 (SH3) module, whilst
actin-binding domains (ABD) possess two calponin homology modules. Coiled-coil rod domains mediate dimerisation. EF-hand motifs bind calcium, and together
with growth-arrest-specific 2-related (GAR) domains and glycine-serine-arginine-rich (GSR) segments are found at the C-termini of some plakin proteins. All plakins
except periplakin contain PRDs of which there are four different subtypes (A, B, C and D), and some possess C-terminal linker (L) modules. B) Schematic re-
presentation of the tripartite domain structure shared by mammalian vimentin, desmin and keratin IF proteins, which encompasses an α-helical central rod flanked
by unstructured ‘head’ and ‘tail’ modules. C) Alignment of PRD sequences from human plakins obtained from Uniprot (accession numbers O60437 (periplakin),
P15924 (desmoplakin), Q92817 (periplakin), Q15149-2 (plectin), Q03001-3 (BPAG1e), Q9UPN3-1 (MACF1b) and Q03001-7 (BPAG1b)) using the PRALINE toolkit
([57] with colours showing the degree of amino acid conservation. Epiplakin PRDs 9-12 have been omitted as they are identical to PRD8. Secondary structure for the
plakin repeat motif is shown (S1, strand1; S2, strand 2, H1, helix 1; H2, helix 2).
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Fig. 2. Molecular basis of plakin PRD/linker module interactions with IFs. A) Ribbon representation and electrostatic surface potential of the desmoplakin PRD1-A
(PDB: 5DZZ), PRD2-B (PDB: 1LM7) and PRD3-C (PDB: 1LM5) and envoplakin PRD-C (PDB: 4QMD). Plakin repeats 1–5 are coloured light orange, cyan, green, salmon
and blue, respectively, with their PR motifs and secondary structural elements labelled. Desmoplakin PRD1-A and PRD2-B also possess an additional PR-like motif at
their N-termini (yellow). PRD-C modules possess a unique clamp feature in PR3 which may assist in IF tethering (highlighted with black dashed lines in envoplakin
PRD-C). The electrostatic surface potential of each PRD was calculated with Delphi and ranges from −7 (red) to +7 (blue) in units of kT/e. Key basic residues are
highlighted. B) Ribbon representation and electrostatic surface potential of an I-TASSER derived periplakin linker model showing PR2-like (pink) and Nt PR-like
(cyan) elements and highlighting the position of basic groove residues. C) Haddock-derived model of the envoplakin PRD bound to coil 1A of dimeric vimentin
(orange). D) Haddock derived model of the periplakin linker complexed with coil 1B of dimeric vimentin (orange). E) Net positive charge distribution within the
groove of human plakin PRDs and linker modules. F) Models of the first PRDs of BPAG1b and MACF1b showing electrostatic surface potential. G) Molecular surface
representation of desmoplakin PRD-AB (PDB: 5DZZ) with their grooves indicated (left). Haddock-derived model of desmoplakin PRD-AB in complex with dimeric
vimentin (PDB: 3UF1) fragments (right). The relative orientation of the grooves suggests that the tandem PRDs are unlikely to bind the same vimentin dimer.
F. Mohammed, et al. BBA - Molecular Cell Research 1867 (2020) 118801
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architectures. The principal features of the vimentin binding groove of
envoplakin are conserved, with broadly similar diameters, lengths and
charge distributions present in the equivalent region of desmoplakin
PRDs [9,27,28]. As keratin and desmin resemble vimentin in presenting
poly-acidic motifs along their rod surfaces [24,30,31], all PRDs may
engage IFs in comparable ways.
The molecular mechanism underpinning periplakin linker interac-
tions with the cytoskeleton is emerging [29]. The periplakin linker
encompasses a broad groove lined by six basic residues (Fig. 2D), of
which three are relatively conserved across plakin linker modules.
Charge reversal mutations of these residues, and of acidic residues
(D176 and E187) in vimentin coil 1B, compromise their interactions
[29]. Consistent with this, mutation of basic residues in the periplakin,
desmoplakin and plectin linker modules disrupts targeting to IFs in
cultured cells [29,32]. In addition, deletion of residues 1694 DWEEI
1698, present in the PR2-like motif of the periplakin linker and prox-
imal to the groove, abolishes IF targeting in transfected cells [13],
probably due to altered orientations of basic groove residues re-
sponsible for IF binding [29]. Overall, linker module-IF interactions are
electrostatic in nature, mirroring the docking pose proposed for PRD-IF
interfaces [9]. A universal cytoskeletal recognition mechanism for
plakins is emerging in which electrostatic attraction mediated by re-
spective basic grooves of series of PRD and linker modules provide the
relevant avidity for stable and dynamic IF tethering.
The individual domains offer divergent functions, as a vimentin rod
construct (residues 99–249) binds more tightly with the envoplakin
PRD (KD = 19 μM) compared to the periplakin linker (KD = 71 μM)
[9,29]. Interestingly, the desmoplakin linker shows no detectable
binding to the same vimentin rod construct despite displaying a groove
with comparable electro-positive surface distribution to the periplakin
linker. Hence, in common with envoplakin PRD-IF interactions, the
propensity for vimentin binding to the linker is not solely defined by
basic character. However, increasing the basic character of the des-
moplakin linker groove does enhance vimentin affinity, albeit not to the
extent of the periplakin linker, indicating that charge is an important
but not exclusive determinant [29]. Evolutionary pressure on peri-
plakin, which does not possess a PRD, may have preserved its stronger
linker-mediated interactions with IFs. By contrast, desmoplakin is
comprised of three juxtaposed PRDs that offer a diverse range of IF
binding surfaces. The envoplakin linker groove encompasses four po-
sitive residues, as opposed to six in the corresponding surface of peri-
plakin (Fig. 2E), suggesting that it might bind more weakly to IFs.
Hence envoplakin may rely on its PRD in combination with the peri-
plakin linker for tighter IF binding in tissues where both are expressed.
Multimerization of plakin proteins offers opportunities to multiplex and
rigidify IF interactions, with the C-terminal binding domain generally
offering the tightest interaction.
The basic grooves of both the envoplakin PRD and the periplakin
linker module accommodate dimeric vimentin rods (Fig. 2C–D). Given
that IFs are organised into higher order structures the question arises as
to what stage of the IF assembly process does interaction with plakin
proteins occur. We envisage two possibilities, either plakin proteins
interact with IFs during assembly or some local untangling of IFs occurs
after assembly allowing plakin protein access to dimeric rods. In either
scenario plakin proteins are likely to be locked into place in fully as-
sembled IFs, increasing the adhesive properties of the interaction.
5. Predicting plakin binding to IFs
To build a predictive basis for IF interactions, molecular models
were generated for all human PRD and linker modules and the net
positive charge distributions within their IF binding groove were de-
termined (Fig. 2E). PRD-A grooves have the least basic character (+1 to
+3), and so are likely to offer the weakest electrostatic-mediated IF
binding. Interestingly, the BPAG1b and MACF1b isoforms exclusively
contain PRD-A subtypes, which may explain their lack of binding to IFs
[10,11]. The sole BPAG1b PRD demonstrates a low net groove charge of
+2, and the N-terminal pair of PRD modules from MACF1b possess net
groove charges of +1 and +2 respectively (Fig. 2E–F). Intriguingly, the
latter mediate Golgi localization, although the mechanism by which
this occurs is unknown [10]. MACF1b encompasses two additional
PRD-A subtypes, with each demonstrating a net groove charge of +3.
These then might be expected to have a moderate IF tethering potential.
However it may be that nearby plakin domain or spectrin repeat region
sterically preclude binding of IFs to these centrally positioned PRDs.
PRD-B domains contain moderately basic grooves (+3 to +4),
whereas PRD-C modules offer highly electropositive grooves (+4 to
+7). In addition PRD-C modules possess a unique PR3 feature com-
prised of an apparently dynamic β-hairpin incorporating a relatively
conserved positively charged side chain that may assist IF tethering by
clamping down and locking a filament into position [9]. PRD-Cs lie
adjacent to linker modules and are found in those plakin proteins
(desmoplakin, plectin and BPAG1e) that are present in cell junctions
and are likely to bind most strongly to IFs. The linker domains con-
necting the PRD-B and C subtypes in these proteins have a net positive
groove charge and are likely to add to the capacity of these proteins to
bind IFs. The basic character of PRD-D modules varies considerably
(+1 to +5) and these domains, primarily found in epiplakin, are dis-
tinguished by divergent PR4-PR5 sequences that cap their grooves.
The homologous PRD/linker modules bearing 1–7 basic determi-
nants could offer graded filament affinities, providing a functional
classification for all PRD/linker superfamily members based on elec-
trostatic complementarity. Overall, there appears to be an inverse
correlation between the net positive charges within PRDs/linker
grooves and the number of PRD elements found in plakin proteins. For
example, plakin proteins with either single PRDs and/or linkers such as
envoplakin and periplakin exhibit the highest net positive groove
charges. Basic character of the grooves is unlikely to be the sole de-
terminant of binding affinity with steric fit and nonpolar contributions
from the variety of available filaments and potential binding partners
likely to be important. Basic residues within the Nt-PR-like motifs of
PRDs -A/-B/-D [27,28] which border the positively charged groove may
also contribute to IF interactions, as could the unstructured intervening
segments between PRDs [12], underscoring the complexity of IF re-
cognition by full length plakins. A spectrum of weak and strong ligands
are also available given that IFs offer multiple potential binding sites
with varying numbers of charged residues. Altogether this implies that
PRD and linker modules are presented with a wealth of opportunities
for flexibly sliding and locking onto filaments, facilitating the dynamic
assembly and disassembly of junctional complexes between epithelial
cell architectures.
6. The role of tandem PRDs
The precise function of plakins encompassing tandem PRDs is ob-
scure. The most obvious possibility is that juxtaposed PRDs offer multi-
valent binding sites that provide high affinity plakin-IF attachments.
Indeed, individual desmoplakin PRDs form weak interactions with vi-
mentin IFs whilst exhibiting stronger co-operative binding when all
three PRDs are present [27]. Furthermore, multiple C-terminal domains
of plectin, including PRD5-B and PRD6-C, bind to keratin 5/keratin 14
in a concerted fashion to ensure efficient association with IF proteins
[8]. Molecular studies of the desmoplakin C-terminal domains have
provided the framework for studying IF interactions with multi-mod-
ular plakins [28]. Small angle X-ray scattering analysis reveals that the
three desmoplakin PRDs and linker form an elongated ‘beads on a
string’ structure [28]. The desmoplakin linker demonstrates a degree of
flexibility suggesting that it may facilitate domain motions that provide
appropriate geometric positioning of flanking PRDs and allowing dy-
namic recognition of targets. We envisage similar functions for plectin
and BPAG1e linker modules.
An intriguing question is whether all four desmoplakin domains
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engage the same IF rod. Molecular surface analysis of the desmoplakin
PRD-AB structure [28] suggests that this is unlikely given the relative
orientations of the IF binding grooves (Fig. 2G, left). Modelling in-
dicates that individual vimentin dimers slot similarly into the desmo-
plakin PRD basic grooves with minimal structural rearrangement. The
lowest energy complex models obtained comprise of each PRD element
interacting with a separate vimentin coil 1 fragment encompassing re-
sidues L146-I249 (PDB: 3UF1) (Fig. 2G, right), consistent with previous
functional studies [7]. This mode of docking suggests that each groove
could accommodate adjacent rods, bringing them together within a
fully assembled IF. By contrast, the envoplakin-periplakin heterodimer
could conceivably bind to the same rod during IF assembly as the en-
voplakin PRD engages with coil 1A of vimentin [9], whereas the peri-
plakin linker module interacts with coil 1B. Delineation of multivalent
binding modes requires further analysis, but could involve sliding of
binding grooves along filaments to secure adaptive attachments.
Development of comprehensive mechanistic insights into how pla-
kins encompassing tandem PRDs engage IFs will require three-dimen-
sional structures of entire IF building blocks. This has proven difficult as
IF proteins form extended coiled-coils that associate into high-order
complexes under wide-ranging ionic environments. Initially the “divide
and conquer” approach was the only viable strategy for generating
atomic resolution data on IFs, with fragments demonstrating mono-
meric, dimeric, or even tetrameric association states within their crystal
lattices [33]. More recently the use of electron paramagnetic resonance
spectroscopy in combination with fragmented structures and molecular
modelling approaches have provided the first experimentally driven
model of a complete IF rod domain [34]. We anticipate that the as-
sembled model will not only provide a basis for exploring IF dynamics
and assembly but will also illuminate ligand docking modes with multi-
domain plakin proteins and define how stable yet dynamic cytoskeletal
attachments are formed.
7. Predicting pathogenic effects of disease-causing mutations
Numerous disease-associated mutations have been documented for
the PRD/linker modules of desmoplakin and plectin (Fig. 3A) in the
Human Gene Mutation Database [35]. Recent PRD and linker structures
allow these to be mapped (Fig. 3B–D). A missense mutation R2366C in
desmoplakin PRD2-B contributes to skin fragility/woolly hair syndrome
[36], and diminishes IF binding [19]. The desmoplakin PRD2-B struc-
ture shows that R2366 mediates a salt bridge between E2290 and
E2293, supporting the PRD fold. The desmoplakin PRD2-B model en-
compassing the R2366C mutation reveals that these interactions would
be abolished, creating structural vulnerabilities (Fig. 3B). In addition,
the thiol group of C2366 may be susceptible to oxidation which could
lead to the formation of physiologically irrelevant disulphide-linked
PRD-B dimers. Similarly, the homozygous missense mutation G2375R
in desmoplakin PRD2-B results in ARVC with skin and hair abnormal-
ities [37], and reduces IF binding [38]. Conserved G2375 residue at the
end of PR3 of PRD2-B executes a sharp turn (Fig. 3C) that is likely to be
conformationally critical (Fig. 1B), with an arginine here unlikely to be
structurally tolerated due to sterically clashes with the N-terminal PR-
like motif (Fig. 3C).
The majority of plectin pathogenic mutations identified are caused
by frameshift and premature termination codon events in the rod do-
main. However, missense mutations in the PRD and linker regions have
been identified (Fig. 3A). For example, the R3527C substitution in
plectin PRD3-B results in EBS [39]. Analysis of the model reveals that
R3527 mediates an ionic interaction with D3523 which contributes to
stabilising the PR3 element (Fig. 3D). Introducing a cysteine at this
position is likely to abolish this contact and adversely affect the PRD
fold (Fig. 3D). These structural models provide the beginning of a
predictive basis for how disease associated mutations affect PRD/linker
stabilities and ligand interactions. These predictions are likely to
improve following structural determination of plakin PRD/linker-IF
complexes.
8. Impact of post translational modifications
There is increasing evidence to indicate that plakin–IF interactions
are regulated by post translational modifications (PTMs) of residues
emanating from PRD and linker modules. Plectin is phosphorylated at
T4542 in PRD6-C by p34cdc2 kinase [40] and a highly reactive cysteine
in PRD5-B serves as a nitrosylation target in vitro [41]. Mutation of
plectin linker module residue S4645 compromises binding to IFs in
transfected cells [42]. Potential phosphorylation sites in plakin PRDs
and linkers were mapped using PhosphoSitePlus [43]. Residues that are
phosphorylated include desmoplakin Y2275 and Y2316 in the first
helices of the PR1 and PR2 motifs of PRD2-B, Y2720 and Y2731 in the
second helix of PR3 of PRD3-C, and the corresponding plectin Y4517
and Y4529 residues in PRD6-C. Since these residues map distal to the
basic groove, phosphorylation may induce long-distance conforma-
tional changes or destabilising effects that disrupt IF binding. The
plectin linker encompasses two additional phosphorylation sites, T4267
and S4268, which given their location, are likely to utilise similar al-
losteric mechanisms for regulating IF tethering. By contrast, other
linker domain residues subject to phosphorylation including S1657 in
periplakin and Y1700 in envoplakin border the positively charged
groove and may directly impact IF interactions.
The GSR region at the extreme C-terminus of plakin proteins confers
an important role in modifying plakin protein-IF interactions. For ex-
ample, phosphorylation of S2849 in the desmoplakin GSR reduces
desmoplakin-IF interactions and promotes desmosome assembly [44].
Phosphorylation of the equivalent residue S4642 in plectin has a similar
effect [45]. Furthermore, methylation of desmoplakin R2834 facilitates
glycogen synthase kinase 3 (GSK3) recruitment, phosphorylation of
nearby serine residues and decreases IF interactions, promoting as-
sembly [46]. Interestingly, R2834 is mutated in ARVC and transgenic
mice engineered to over-express human desmoplakin containing this
mutation exhibit increased cardiac fibrosis, apoptosis and lipid accu-
mulation, as well as ventricular enlargement and cardiac dysfunction
[47]. Although a direct correlation between delays in desmosome as-
sembly and ARVC pathogenesis remains to be established, it is inter-
esting to note that GSK3β is mislocalised to the intercalated disk in
ARVC patients and its pharmacological inhibition improves cardiac
histology and function in ARVC models [48]. Since the GSR domains of
desmoplakin and plectin are highly conserved these complex cytoske-
letal regulations are likely to be more widespread.
Finally, IF networks are highly dynamic with individual filaments
undergoing constant reshaping [49]. PTM events such as phosphor-
ylation and glycosylation play a pivotal role in regulating IF dynamics
[50] and this adds another layer of complexity to the already be-
wildering plakin-IF interaction landscape. Further studies are un-
doubtedly required to establish the precise interplay between PTMs in
regulating IF assembly and plakin binding.
9. Plakin proteins as orchestrators of IF reorganisation
The role of plectin in organising IF architecture is well established
[51]. It anchors IFs to junctional complexes, organelles and the nuclear
envelope and engages microfilaments and microtubules. In its absence
IF networks are aberrantly organised and can collapse, particularly in
muscle cells [51]. Other plakin proteins are also critical for regulating
IF networks. The conserved K1646 near the beginning of the periplakin
linker is SUMOylated in response to stress-mediated reorganisation of
keratin and regulates cytoskeletal reorganisation [52]. It is possible that
following the covalent conjugation of the periplakin linker with SUMO-
1, a globular protein with distinct electropositive surface patches, the
linker module exhibits a greater capacity to accommodate negatively
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charged keratin rod elements. Epiplakin is highly expressed in the
epidermis, but unlike other plakins, its loss does not result in skin fra-
gility and blistering [53]. However, like periplakin, it assists in keratin
IF reorganisation and ensures resistance to experimentally induced
disruption [54–56]. Together, these reports suggest that plakin PRD and
linker domains possess functions beyond simply tethering IFs to the
membrane in order to maintain and regulate tissue integrity.
10. Conclusion
Substantial progress is being made in our understanding of the
mechanistic basis of plakin protein-IF interactions based on recent
structural and functional studies of PRD and linker modules, and IF rod
domains. This has informed the development of models for mapping
pathogenic mutations and accurately predicting their impact on struc-
tures. However, the molecular basis of how pathogenic mutations lead
to disorders such as ARVC is far from established. Pathogenicity of
mutations could result from reduced IF interactions, although addi-
tional effects could include altered protein stability, trafficking, ligand
binding dynamics, intracellular signalling and cell adhesion. Despite
the emerging picture about the physiological and pathological functions
of PRD/linker module interactions, several questions remain un-
answered. The molecular basis underpinning the specificity and dif-
ferential binding of PRDs/linker module elements to IFs are obscure.
How higher order IF structures modulate plakin interactions or drive
disease progression remains to be characterised, necessitating struc-
tures of complexes. How multiple PTMs mediate the dynamic interplay
of plakin-IF attachments remains elusive. Recent advances in proteomic
approaches could contribute new insights into the plakin interactome
including of the stages of IF reorganisation, presenting tantalizing
avenues for future research.
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